-

Gabelli Healthcare & WellnessRx Trust Welcomes Jennie Tsai, Jing He, and Sara Wojda Portfolio Managers

RYE, N.Y.--(BUSINESS WIRE)--GAMCO Investors, Inc., (NYSE: GBL) announces the appointment of Jennie Tsai, Jing He, and Sara Wojda to the investment team of the Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) (the “Fund”) effective January 1, 2021.

Commenting on the appointments, Mr. Gabelli said, “We are delighted to have Jennie, Jing, and Sara join the Healthcare & WellnessRx Trust team. They all have excellent foundations in Gabelli research that make them valuable additions to help our team meet the objectives of (y)our Fund.”

Jennie Tsai is a portfolio manager and analyst with 20 years’ experience investing in healthcare companies, specializing in medical devices. She joined Gabelli in 2001 after receiving an MBA from Columbia Business School and B.S. in Commerce from the University of Virginia.

Jing He is a portfolio manager and biotech analyst covering the biopharmaceutical industry. She joined Gabelli Funds in 2015 after receiving an MBA from Columbia Business School. Prior to that, she worked at Regeneron Pharmaceuticals as a scientist in drug research and development. She holds a Masters in Chemistry from Washington University in St. Louis and B.S. in Chemistry from Peking University.

Sara Wojda joined the firm in 2014 as a research analyst and covers the diagnostics and life sciences industries. Since moving to London in 2018, she has expanded the firm’s global healthcare coverage and assisted with the Gabelli U.K. based funds. Sara graduated summa cum laude from Babson College with a B.S. in Business Management, double-majoring in Economics and Accounting.

Investors should carefully consider the investment objectives, risks, charges, and expenses of the Fund before investing. More information regarding the Fund’s distribution policy and other information about the Fund is available by calling 800-GABELLI (800-422-3554) or visiting www.gabelli.com.

About The Gabelli Healthcare & WellnessRx Trust

The Gabelli Healthcare & WellnessRx Trust is a diversified, closed-end management investment company with $282 million in total net assets whose primary investment objective is long-term growth of capital. The Fund is managed by Gabelli Funds, LLC, a subsidiary of GAMCO Investors, Inc. (NYSE:GBL).

NYSE: GRX
CUSIP – 36246K103

Contacts

Investor Relations Contact:
Bethany Uhlein
914.921.5546
buhlein@gabelli.com

Industry:

Gabelli Healthcare & WellnessRx Trust

NYSE:GBL
Release Versions
English

Contacts

Investor Relations Contact:
Bethany Uhlein
914.921.5546
buhlein@gabelli.com

More News From Gabelli Healthcare & WellnessRx Trust

Gabelli Healthcare & WellnessRx Trust Declares First Quarter Distribution of $0.15 Per Share

RYE, N.Y.--(BUSINESS WIRE)--The Board of Trustees of The Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) (the “Fund”) declared a $0.15 per share cash distribution payable on March 24, 2023 to common shareholders of record on March 17, 2023. The Fund intends to pay a quarterly distribution of an amount determined each quarter by the Board of Trustees. In addition to the quarterly distributions, and in accordance with the minimum distribution requirements of the Internal Revenue Code for reg...

Gabelli Healthcare & WellnessRx Trust Announces Initial Closing of Private Placement of 5.20% Series G Cumulative Preferred Shares

RYE, N.Y.--(BUSINESS WIRE)--The Board of Trustees of The Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) (the “Fund”) is pleased to announce the initial closing of a private placement of 5.20% Series G Cumulative Preferred Shares (“Series G Preferred”) with an aggregate liquidation value of $21 million. The Series G Preferred is non-callable until June 26, 2025, and has a liquidation preference of $10 per share. Distributions are scheduled to be paid semiannually beginning on June 26, 2023....

Gabelli Healthcare & WellnessRx Trust Declares Fourth Quarter Distribution of $0.15 Per Share

RYE, N.Y.--(BUSINESS WIRE)--The Board of Trustees of The Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) (the “Fund”) declared a $0.15 per share cash distribution payable on December 16, 2022 to common shareholders of record on December 9, 2022. The Fund intends to pay a quarterly distribution of an amount determined each quarter by the Board of Trustees. The Board of Trustees may change the amount of the quarterly distribution at any time. In addition to the quarterly distributions, and i...
Back to Newsroom